Different interaction between tricyclic antidepressants and mecamylamine with the human alpha3beta4 nicotinic acetylcholine receptor ion channel. 2010

Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
Department of Pharmaceutical Sciences, College of Pharmacy, Midwestern University, Glendale, AZ 85308, USA. harias@midwestern.edu

The interaction of tricyclic antidepressants (TCAs) with the human (h)alpha3beta4 nicotinic acetylcholine receptor (AChR) in different conformational states was compared with that for mecamylamine by using functional and structural approaches including, Ca(2+) influx, radioligand binding, and molecular docking. The results established that: (a) [(3)H]imipramine binds to a single site with relatively high affinity (K(d) = 0.41 +/- 0.04 microM), (b) imipramine inhibits [(3)H]imipramine binding to the resting/kappa-bungarotoxin-bound AChR (K(i) = 0.68 +/- 0.08 microM) with practically the same affinity as to the desensitized/epibatidine-bound AChR (K(i) = 0.83 +/- 0.08 microM), suggesting that TCAs do not discriminate between these conformational states, and (c) although TCAs (IC(50) approximately 1.8-2.7 microM) and mecamylamine (IC(50) = 3.3 +/- 0.4 microM) inhibit (+/-)-epibatidine-induced Ca(2+) influx with potencies in the same concentration range, TCAs (K(i) approximately 1-3.6 microM), but not mecamylamine (apparent IC(50) approximately 0.2 mM), inhibit [(3)H]imipramine binding to halpha3beta4 AChRs in different conformational states. This is explained by our docking results where imipramine, in the neutral and protonated states, interacts with the leucine (position 9') and valine/phenylalanine (position 13') rings, whereas protonated mecamylamine (>99% at physiological pH) interacts with the outer ring (position 20'). Our data indicate that TCAs bind to overlapping sites located between the serine and valine/phenylalanine rings in the halpha3beta4 AChR ion channel, whereas protonated mecamylamine can be attracted to the channel mouth before blocking ion flux by interacting with a luminal site in its neutral state.

UI MeSH Term Description Entries
D007099 Imipramine The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. Imidobenzyle,Imizin,4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)-3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine (1:2),Imipramine Hydrochloride,Imipramine Monohydrochloride,Imipramine Pamoate,Janimine,Melipramine,Norchlorimipramine,Pryleugan,Tofranil
D007473 Ion Channels Gated, ion-selective glycoproteins that traverse membranes. The stimulus for ION CHANNEL GATING can be due to a variety of stimuli such as LIGANDS, a TRANSMEMBRANE POTENTIAL DIFFERENCE, mechanical deformation or through INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS. Membrane Channels,Ion Channel,Ionic Channel,Ionic Channels,Membrane Channel,Channel, Ion,Channel, Ionic,Channel, Membrane,Channels, Ion,Channels, Ionic,Channels, Membrane
D008464 Mecamylamine A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes

Related Publications

Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
November 1981, Molecular pharmacology,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
September 2001, Molecular pharmacology,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
July 1986, European journal of biochemistry,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
April 1989, Sheng li ke xue jin zhan [Progress in physiology],
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
May 1989, European journal of pharmacology,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
July 2018, The international journal of biochemistry & cell biology,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
February 2021, Molecules (Basel, Switzerland),
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
August 1986, Neurochemical research,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
March 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Hugo R Arias, and Katarzyna M Targowska-Duda, and Dominik Feuerbach, and Carl J Sullivan, and Ryszard Maciejewski, and Krzysztof Jozwiak
May 2010, Biochemistry,
Copied contents to your clipboard!